⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16541693 | 0.86 | — | — | |
| SCHEMBL31470922 | 0.77 | — | — | |
| SCHEMBL1059408 | 0.76 | — | — | |
| SCHEMBL9215113 | 0.76 | — | — | |
| SCHEMBL11544540 | 0.76 | — | — | |
| Ethaneperoxoic Acid SCHEMBL31288482 | 0.74 | — | — | |
| SCHEMBL11791853 | 0.73 | DPP4 (0.34) | — | |
| SCHEMBL427806 | 0.67 | — | — | |
| Acetic Acid SCHEMBL31591661 | 0.67 | CA1 (0.38) | — | |
| SCHEMBL9178658 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108370061-B | Solid electrolyte composition, binder particle, all-solid-state secondary battery, sheet, electrode sheet, and method for producing same | 富士胶片株式会社 | 2021-12-31 | — | — | CN | disclosed |
| CN-113135908-A | Preparation method of tizanidine hydrochloride | 杭州泓友医药科技有限公司 | 2021-07-20 | — | — | CN | disclosed |
| EP-1918287-A2 | LPA receptor agonists and antagonists and methods of use | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2008-05-07 | — | — | EP | disclosed |
| EP-1263752-B1 | LPA RECEPTOR AGONISTS AND ANTAGONISTS AND METHODS OF USE | UNIV TENNESSEE RES CORP (US) | 2007-12-05 | — | — | EP | disclosed |
| EP-1427424-A4 | LPA RECEPTOR AGONISTS AND ANTAGONISTS AND METHODS OF USE | UNIV TENNESSEE RES CORP (US) | 2006-12-13 | — | — | EP | disclosed |
| US-20050261252-A1 | LPA receptor agonists and antagonists and methods of use | MILLER DUANE D | 2005-11-24 | — | — | US | disclosed |
| US-6875757-B2 | For therapy of cancer, enhancing cell proliferation, and wound | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2005-04-05 | — | — | US | disclosed |
| EP-1427424-A2 | LPA RECEPTOR AGONISTS AND ANTAGONISTS AND METHODS OF USE | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-1263752-A4 | LPA RECEPTOR AGONISTS AND ANTAGONISTS AND METHODS OF USE | UNIV TENNESSEE RES CORP (US) | 2003-07-30 | — | — | EP | disclosed |
| US-20030130237-A1 | LPA receptor agonists and antagonists and methods of use | MILLER DUANE D (US) | 2003-07-10 | — | — | US | disclosed |
| WO-2001071022-A2 | LPA RECEPTOR AGONISTS AND ANTAGONISTS AND METHODS OF USE | THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) | 2001-09-27 | — | — | WO | disclosed |
| US-5237072-A | Contacting an imidazoline sulfonic acid with at least one amine component in presence of alcohol-containing liquid | ALLERGAN, INC. (US) | 1993-08-17 | — | — | US | disclosed |
| US-5130441-A | Reaction of an imidazoline sulfonic acid with an amine in the presence of an alcohol | ALLERGAN, INC. (US) | 1992-07-14 | — | — | US | disclosed |
| EP-0081923-B1 | 2-(TRISUBSTITUTED PHENYLIMINO)-IMIDAZOLINES | ALCON LABORATORIES, INC. (US) | 1987-01-21 | — | — | EP | disclosed |
| EP-0081924-B1 | TOPICAL COMPOSTIONS FOR LOWERING INTRAOCULAR PRESSURE | ALCON LABORATORIES, INC. (US) | 1986-02-19 | — | — | EP | disclosed |
| US-4517199-A | TREATMENT OF GLAUCOMA | ALCON LABORATORIES, INC. (US) | 1985-05-14 | — | — | US | disclosed |
| US-4515800-A | GLAUCOMA | ALCON MANUFACTURING, LTD. | 1985-05-07 | — | — | US | disclosed |
| US-4461904-A | 2-(Trisubstituted phenylimino)-imidazolines | ALCON LABORATORIES, INC. (US) | 1984-07-24 | — | — | US | disclosed |
| EP-0081923-A2 | 2-(Trisubstituted phenylimino)-imidazolines | ALCON LABORATORIES, INC. (US) | 1983-06-22 | — | — | EP | disclosed |
| EP-0081924-A1 | Topical compostions for lowering intraocular pressure | ALCON LABORATORIES, INC. (US) | 1983-06-22 | — | — | EP | disclosed |